The Action to Control Cardiovascular Risk in Diabetes Study Group.Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med2008; 358: 2545-59.
2.
The Advance collaborative group.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med2008; 358: 2560-72.
3.
Duckworth W. , Abraira C., Morritz T. et al. Glucose control and vascular complications in veterans with type 2 diabetes. New Engl J Med2009; 360:129-39.
4.
Cradock S., Frier BM Determining the risk of hypoglycaemia people with type 2 diabetes - an approach for clinical practice. Br J Diabetes Vasc Dis2010; 10: 44-46
5.
Alex J.Graveling AJ, Frier BMDoes hypoglycaemia cause cardiovascular events?Br J Diabetes Vasc Dis2010; 10: 5-13
6.
Fisher M.Hypoglycaemia in patients with type 2 diabetes: minimising the risk . Br J Diabetes Vasc Dis2010; 10: 35-41
7.
Bergenstal RM , Bailey CJ, Kendall DMTherapeutic decision-making in type 2 diabetes: assessing the relative risks and benefits of glucose-lowering medications . Am J Med2009; in press DOI 10.1016/J. AMJMED.2009.07.017
8.
Amiel SA, Dixon T., Mann R., Jameson K.Hypoglycaemia in type 2 diabetes. Diabetic Med2008; 25: 245-54.
9.
Cryer PEThe barrier of hypoglycaemia in diabetes. Diabetes2008; 57:3169-76.
10.
Davis RE, Morrisey M., Peters JR et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin2005; 21: 1477-83.
11.
Leese GP, Wang J., Bromhall J., Kelley P. et al. Frequency of severe hypoglycaemia requiring emergency treatement in type 1 and type 2 diabetes. Diabetes Care2003; 26: 1176-80.
12.
Brackenridge A., Wallbank H., Lawrenson RA, Russell-Jones D.Emergency management of diabetes and hypoglycaemia . Emerg Med J.2006; 23:183-5.
13.
Krentz AJ, Bailey CJOral antidiabetic agents: current role in type 2 diabetes mellitus . Drugs2005; 65: 385-411.
14.
Krentz AJ, Patel MB, Bailey CJNew drugs for type 2 diabetes mellitus: what is their place in therapy?Drugs2008; 68:2131-62
15.
, Huang Z., Sjoholm A.Ethanol acutely stimulates islet blood flow, amplifies insulin secretion and induces hypoglycaemia via NO and vagally mediated mechanisms. Endocrinology2008; 149: 232-6.
16.
Hori S., Kizu J., Kawamura M.Effect of fluoroquinolones on plasma glucose levels in fasted and glucose-loaded mice. J Infection Chemotherapy2006; 12: 109-11
17.
Ferner RE, Kendall MJDrug therapy: special considerations in diabetes. In Textbook of diabetes. Pickup JC, Williams G (eds) 3rd edn. Blackwell, Oxford2003 ,pp39.1-39.12.
18.
Ueno N., Inui A., Asakawa A. et al. Erythromycin improves glycaemic control in patients with type II diabetes mellitus. Diabetologia2000; 43: 411-5.
19.
Goodnick PJ , Henry JH, Buki VMTreatment of depression in patients with diabetes mellitus. J Clin Psychiatry1995; 56: 128-36
Whitmer RA, Karter AJ, Yaffe K. et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitusJAMA. 2009;301:1565-72.
22.
Bailey CJGlycaemic control: how intensive? Webcast. Session: Oral antidiabetic agents - recent endpoint trials. EASD2008 . http://www.easd.org/easdwebfiles/annualmeeting/44thmeeting/webcasts/webcasts.htm (Accessed January 2010)
23.
Cox DJ, Irvine A., Gonder-Frederick L., Nowacek G., Butterfield J.Fear of hypoglycemia: quantification, validation and utilization. Diabetes Care1987, 10:617-621.
24.
Stargardt T. , Gonder-Frederick L., Krobot KJ, Alexander CMFear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes. Health and Quality of Life Outcomes2009; 7:91 doi:10.1186/1477-7525-7-91
25.
Perlmuter LC , Flanagan BP, Shah PH, Singh SPGlycemic control and hypoglycemia. Is the loser the winner?Diabetes Care2008; 31:2072-76.
26.
Huang ES, Brown SES, Ewigman BG, et al. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care30: 2478-83, 2007.
27.
Hammer M., Lammert M., Monereo Mejias S. et al Costs of managing severe hypoglycaemia in three European countries . J Med Economics2009; 12: 281-90.